Objectives: To perform the first multinational Enterobacter cloacae clonality study, using the MLST scheme newly developed in Japan.
Introduction
The Enterobacter cloacae complex comprises major human pathogens of the genus Enterobacter, responsible for numerous nosocomial infections, especially among ICU patients.
1,2 Like other Enterobacteriaceae, they colonize the intestine, creating a reservoir for infection in debilitated patients upon prolonged hospitalization and antibiotic treatments. 1 Antimicrobial resistance complicates therapy of E. cloacae infections. Along with other enterobacters, it has an inducible AmpC-type cephalosporinase, conferring intrinsic resistance to first-and secondgeneration cephalosporins and to penicillins and their inhibitor combinations. Moreover, the apparently frequent regulatory mutations cause constitutive AmpC hyperproduction (derepression), resulting in resistance to most of the expanded-spectrum cephalosporins (ESCs) and aztreonam. 3 -5 The other source of enterobacterial resistance to newer b-lactams consists of acquired b-lactamases, including ESBLs and carbapenemases such as metallo-b-lactamases (MBLs), KPCs and OXA-48-like enzymes. Their global spread in Enterobacteriaceae, mainly Escherichia coli and Klebsiella pneumoniae, is currently the main threat to therapy of infections. 6 -8 All of these enzymes have been reported increasingly worldwide in E. cloacae as well. 5,9 -25 MLST has revolutionized clonal structure analyses of bacterial populations, allowing reliable large-scale epidemiological and evolutionary studies. Regarding Enterobacteriaceae, the first MLST schemes were introduced for E. coli, K. pneumoniae and Salmonella enterica in the mid-2000s, 26 -28 and this produced a large body of knowledge on, for example, pandemic clones of these organisms. 29 In contrast, little is known about E. cloacae clonality; however, the MLST scheme established in Japan in 2013 30 has opened the way to changing this situation. The aim of this work was to perform the first multinational MLST analysis of E. cloacae, using a large number of rectal carriage isolates collected from patients during the EU-funded project MOSAR.
Methods

Study design, clinical isolates and their phenotypic analysis
Twelve clinical centres participated in the study. These were seven ICUs located in France (centre HM), Greece (AT and LA), Italy (CA), Latvia (RI), Luxembourg (LU) and Slovenia (LJ), and five rehabilitation units (RUs) in France (BM), Israel (LH and TA), Italy (FS) and Spain (GI). From the mid-2008s until the mid-2011s, rectal cultures were collected from all patients at admission, then regularly during hospitalization, and at discharge. Rectal swabs were plated onto Brilliance TM ESBL Agar (Oxoid, Basingstoke, UK); Enterobacteriaceae colonies were identified using the manufacturer's instructions. One colony of each morphotype was stored for definite analysis. Species identification was done with the Vitek 2 system (bioMérieux, Marcy-l'Étoile, France). Phenotypic detection of ESBL and AmpC expression was carried out by the ESBL double-disc synergy test (DDST) using cefotaxime, ceftazidime, cefepime and amoxicillin with clavulanate discs in the absence and presence of 250 mg/L cloxacillin. 31 E. cloacae isolates resistant to cefotaxime and ceftazidime without synergism with clavulanate (regardless of the result obtained with cefepime) and with inhibition zones augmented upon cloxacillin were classified as organisms with putative AmpC high-level expression. Susceptibility to carbapenems was tested using ertapenem, imipenem and meropenem discs, and interpreted according to EUCAST (http://eucast.org). Phenotypic MBL detection was carried out by the DDST with EDTA, 32 whereas the presence of KPC was detected by the combined disc test with phenylboronic acid. 33 Of the total of 545 E. cloacae isolates collected, 195 patient-unique isolates were selected for the molecular study. All non-duplicate isolates identified in a given centre were included, unless there were .30 isolates (centres HM, RI and TA), in which case 30 isolates were randomly selected. The number of isolates from the other centres was ,10 for five sites (CA, n¼6; GI, n¼6; LA, n¼9; LJ, n¼4; LU, n¼7) and between 10 and 30 for the remaining four sites (AT, n¼17; BM, n¼18; FS, n¼22; LH, n¼16).
Typing and nucleotide sequence analysis PFGE was performed as described, 34 with the use of the XbaI restriction enzyme (Fermentas, Vilnius, Lithuania). PFGE types and subtypes were distinguished visually using the criteria of Tenover et al. 35 Electrophoretic patterns were also compared by BioNumerics Fingerprinting (Version 6.01, Applied Maths, Sint-Martens-Latem, Belgium) using the Dice coefficient and the UPGMA clustering method, with 1% tolerance in band position differences. MLST was carried out as described previously; 30 the database available at http://pubmlst.org/ecloacae was used for assigning STs. The relatedness between STs was analysed by eBURST (http://eburst.mlst. net). The clonal diversity indexes and CIs were calculated according to Grundmann et al. 36 Nucleotide diversity was calculated using DnaSP Ver. 5.10.01. 37 Phylogenetic analysis of nucleotide sequences was performed using Lasergene MegAlign software (DNASTAR Inc., Madison, WI, USA) using CLUSTAL W alignment. Searches of the GenBank database were carried out using the NCBI BLASTn option (www.ncbi.nlm.nih.gov).
b-Lactamase analysis
Identification of bla CTX-M -, bla SHV -, bla TEM -, bla VIM -and bla KPC -like genes was done by PCRs. 9,38 -40 Sequencing of the genes was performed as reported, 9,39,41 using sets of consecutive primers specific for each gene type.
Nucleotide sequence accession numbers
The bla SHV-183 gene sequence appears in the EMBL database with accession number HG934764.
Results and discussion
Comparison of MLST and PFGE
The report on the E. cloacae MLST scheme 30 did not include a comparison between MLST and PFGE, which so far has been used as a standard typing approach for Enterobacteriaceae. 42 We therefore performed such an analysis in this study. First, all 195 of the E. cloacae isolates were typed by PFGE, and this was followed by MLST of 173 isolates, representing each PFGE pattern and in a few cases having identical patterns. The results are shown in Table 1 , Table S1 (available as Supplementary data at JAC Online) and Figure S1 . The isolates produced 169 different PFGE patterns clustered into 129 pulsotypes, and were classified into 88 STs by MLST. The PFGE and MLST data correlated well with each other, with PFGE being more discriminatory. Twenty-two STs were split into two to six pulsotypes; the most diverse STs were ST78 and ST108. In most cases, isolates representing different subtypes of the same pulsotype belonged to the same ST. The only exceptions were three single-locus variant (SLV) pairs (ST78 and ST86, ST133 and ST140, and ST136 and ST159), in which isolates of one ST clustered within one of the pulsotypes of the other ST. Sequences of the alleles differentiating the SLVs varied by only a single point mutation in each pair, indicating direct clonal evolution between the SLVs. This was supported by the results of the nucleotide diversity analysis within the sample, performed on alleles of each MLST gene and their concatenated sequences for all of the 88 STs. The results (Table S2 ) demonstrated significant diversity of the MLST genes overall (p, 0.32% -6.17%), which was congruent also with the data from Japan. 30 Clonal structure of the E. cloacae population (Tables 1 and S1 ). The clonal diversity index for the whole collection was 97.5% (CI, 96.6% -98.4%), indicating high genetic diversity in general.
Concatamers of the MLST alleles of the 88 STs were subjected to phylogenetic analysis. The phylogenetic tree comprised 12 clusters of closely related STs, designated A -L ( Figure S2 ). Since E. cloacae is a complex of several species and subspecies, 2 12 STs representing each lineage were compared with GenBank sequences, using their concatamer and MLST fragments of the rpoB gene. 2 For most of the STs, the best identity scores were obtained with whole-genome sequence entries of organisms defined as 'E. cloacae' or 'E. cloacae subsp. cloacae', including the ATCC 13047 (GenBank accession number NC_014121.1) and NCTC 9394 (NC_021046.1) strains ( Figure S3 ). ST162 was most similar to Enterobacter asburiae L1 (CP007546.1) by both the concatamer and rpoB, and so was ST130 by rpoB. However, the ST130 and ST162 isolates were motile, which excludes the E. asburiae Enterobacter cloacae international clones 43 Considering also that two E. asburiae sequences found in the analysis did not separate from E. cloacae and that corresponding sequences of other E. cloacae complex members were not available, definite (sub)species identification of the study isolates was not possible. Therefore, these were interpreted as E. cloacae in the broad sense.
All of the STs were analysed by eBURST against the entire MLST database, containing 241 STs (as of 7 May 2014), in order to reveal their relationships with all STs identified so far (Figure 1 ). Of the 88 STs, 53 (60.2%) were singletons, 8 (9.1%) had single SLVs and 27 (30.7%) clustered within 13 bigger eBURST groups (from 3 to 14 STs each), including clonal complexes (CCs) (Tables 1 and S1 ). Five such groups encompassed 76 isolates (39.0%) of 13 STs, and isolates of each of these were from at least four countries (Table 1) .
Twenty-one isolates from six hospitals in France, Italy, Latvia and Israel belonged to the two SLVs ST78 (n ¼ 20) and ST86 (n ¼ 1), which, together with 10 other STs submitted from Japan 30 or France (D. Girlich; http://pubmlst.org/ecloacae), may form a CC with ST74 as the central genotype, CC74. ST78, originally identified in Japan, was the most prevalent and one of the most widespread STs in this study. It comprised five pulsotypes, with one type prevailing (n ¼ 15) and grouping isolates from French (BM, HM) and Latvian (RI) centres.
Twenty-three isolates from France, Italy, Spain, Greece and Israel (seven hospitals) were of ST66 (n ¼ 10) or ST114 (n ¼ 13). ST114 might be the central genotype for CC114, encompassing also four other STs submitted from Japan 30 or France (D. Girlich; N. Khennouchi; http://pubmlst.org/ecloacae). ST66 was described first in Japan; in our study it had three pulsotypes, one of which was distributed in France (HM), Spain (GI) and Israel (LH, TA). One of four ST114 pulsotypes clustered 10 isolates in HM.
Fourteen isolates from France, Italy, Spain, Latvia and Israel (seven hospitals) represented ST45 (n ¼ 3), ST50 (n ¼ 6), ST107 (n ¼ 1), ST112 (n ¼ 1) and ST124 (n ¼ 2), which form CC234 with nine other STs submitted from Japan, 30 France (D. Girlich; P. Cholley; N. Khennouchi; http://pubmlst.org/ecloacae) and the United Arab Emirates (A. Sonnevend; http://pubmlst.org/ ecloacae). The isolates belonged to 10 site-specific pulsotypes.
Eleven isolates from France, Italy, Luxembourg and Greece (six hospitals) belonged to ST108, which had two SLVs submitted from France (D. Girlich; P. Cholley; http://pubmlst.org/ecloacae). It was diversified into six pulsotypes, with one identified in one Italian centre (FS) and one Greek centre (AT).
Seven isolates of different pulsotypes from four centres in France, Luxembourg, Latvia and Israel belonged to ST118 (n¼ 4), ST145 (n¼ 2) and ST152 (n¼1), related to each other and to one more ST submitted from France (P. Cholley; http://pubmlst.org/ecloacae).
All SLV pairs identified by eBURST within the five groups, including the STs not found in this study, were checked for numbers of polymorphisms in the differentiating alleles, and these numbers were low (one to seven; usually one to three). The eBURST results were analysed against the phylogenetic tree ( Figure S2 ); all STs in one eBURST group were also in the same lineage, and all SLV pairs in the sample were the closest relatives. Regarding the high nucleotide diversity within the sample overall (Tables S2 and  S3) , these results suggest a remarkable role of clonal evolution within the eBURST groups. However, recombination cannot be excluded entirely either, especially within the CCs with straggly structures, such as CC74 or CC234. Total numbers of b-lactamases may not be equal to numbers of isolates because of multiple cases of co-production of two or more acquired enzymes. g Overall 14 isolates were classified into these STs based on the identity of their PFGE patterns with isolates subjected to MLST.
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All these observations, together with the limited data in the MLST database, suggest that the five clonal groups represent genetic lineages of higher prevalence and/or wider geographical spread. Some STs are of particular interest, namely ST78, ST66, ST114 and ST108, each represented by at least 10 isolates from several countries, diversified into multiple pulsotypes, with clusters of closely related isolates in one or more hospitals. They might be of epidemic or even pandemic potential, similar to some E. coli or K. pneumoniae clones.
29,44 -46
AmpC, ESBLs and carbapenemases
The AmpC overexpression phenotype was shown by 101 isolates. Of these, 20 isolates were tested by PCR for acquired AmpC types, 47 yielding a product only with primers for the E. cloacae-derived bla MIR-1 gene. Therefore, all of the 101 isolates might have the natural AmpC derepressed (Tables 1 and S1 ). In 95 isolates (48.7%) of 66 STs this was the only identified mechanism of b-lactamase-mediated resistance to ESCs. Such isolates dominated (.75%) in one French hospital (BM) and two Greek hospitals (AT and LA).
In the 100 remaining isolates (including 6 AmpC hyperproducers) of 38 STs, acquired ESC-hydrolysing enzymes were revealed, being ESBL, KPC and MBL types (Tables 1, S1 and S4). The most prevalent were ESBLs, produced by 96 isolates (49.2% of all isolates), followed by MBLs (n ¼ 6; 3.1%) and KPCs (n ¼ 3; 1.5%) (Table S4 ). Twenty isolates co-expressed two or three such b-lactamases and these were double ESBL producers (n ¼ 15; 7.7%) or ESBL plus MBL (n¼3) or ESBL plus KPC co-producers (n¼2).
CTX-M-like enzymes were the most common ESBLs, present in 74 isolates (77.1% of isolates with ESBLs), followed by SHVs (n¼ 32; 33.3%) and TEMs (n¼ 2; 2.1%). Of seven CTX-M variants, CTX-M-15 was the most frequent; it was expressed by 58 isolates (60.4% of ESBL producers) of 15 STs and 18 pulsotypes from seven countries (nine hospitals). Of four SHV variants, SHV-12 was also widespread, with 24 isolates (25.0% of ESBL producers) of 15 STs and 19 pulsotypes from six countries (eight centres). SHV-183, from an ST62 isolate from Slovenia (LJ), is a novel enzyme that differs from SHV-12 by one additional alanine residue inserted between M186 and A187.
One-hundred and fifteen isolates showed reduced susceptibility to one or more carbapenems (http://eucast.org). Nine isolates were phenotypically positive for KPC or MBL production, confirmed by PCR and sequencing. KPC-2 was found in three isolates of different STs, all from the Israeli RUs (LH and TA) ( Tables 1, S1 and S4). The MBL was VIM-1, produced by six isolates of different STs from Italy (FS), Greece (LA) and Latvia (RI). All of the carbapenem-non-susceptible isolates were tested by PCR for the presence of bla OXA-48 -like genes and the results were negative.
The b-lactamase data reflect well the current epidemiological knowledge. 19,48 -53 Two points are worth noting. First, despite the long-lasting spread of ESBLs, AmpC derepression remains an equally important ESC resistance mechanism in E. cloacae. 3, 4 Its highly polyclonal character (diversity index, 98.4%; CI, 97.5% -99.2%) suggests that this mechanism is sporadically associated with clonal spread, in contrast to CTX-M-15 expression (diversity index, 88.0%; CI, 83.3% -92.6%). Second, although CTX-M-15 prevailed among ESBL producers, it was not as Enterobacter cloacae international clones 53 JAC ubiquitous among E. cloacae as among E. coli or K. pneumoniae isolates from the same centres. 54, 55 'Major' clones versus b-lactamases b-Lactamase profiles observed in the major E. cloacae clonal groups revealed interesting differences among these ( Table 1) . Some of them readily acquired the ESC-hydrolysing enzymes: 18/21 isolates of all CC74 pulsotypes produced such b-lactamases, and so did 6/7 isolates and pulsotypes of the ST118 -ST145 -ST152 group. On the other hand, as few as 4/14 isolates of 3/10 pulsotypes of CC234 expressed the acquired enzymes. None of the most prevalent and widespread E. cloacae clones (ST78, ST66, ST114 and ST108) demonstrated one b-lactamase profile. Each of these included a few isolates with only AmpC hyperproduction ( Table 1) ; they also had multiple isolates with acquired enzymes, including different ESBLs but also VIM-1 or KPC-2. CTX-M-15 prevailed in ST78, ST66 and ST114, and it was associated with the three pulsotypes mentioned above, broadly disseminated in particular centres (HM) or across centres (HM, GI, RI, LH, TA).
These results indicate the lack of a strict correlation between b-lactamase profiles and most of the prevalent and widespread E. cloacae clones. They suggest that, like E. coli and K. pneumoniae, such E. cloacae clones have been spreading by themselves, locally acquiring plasmids with b-lactamase genes, and that the acquisition of CTX-M-15 might have made specific pulsotypes better fitted for further expansion. 29,44,54 -57 It might also be possible that some clones have been less predisposed than others to harbouring foreign b-lactamase genes.
Conclusions
This study directly follows the original report on the new MLST scheme for E. cloacae 30 and is the first multinational clonal analysis of this important pathogen. Several observations suggest that, like E. coli and K. pneumoniae, E. cloacae comprises a number of lineages, spreading on a wide geographical scale and acquiring resistance traits, such as various ESBLs and carbapenemases. 29 Even though the study was performed on rectal carriage isolates, it is probable that at least some of these clones are responsible for infections, being organisms of high clinical relevance. Since clonality studies on E. cloacae have just commenced, future work is needed to confirm and expand these data. 
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